Table 1 Characteristics of the four living labs implementing evidence based medication adherence interventions in the Dutch primary care system
From: Implementing medication adherence interventions in four Dutch living labs; context matters
| Â | Living lab A | Living lab B | Living lab C | Living lab D |
|---|---|---|---|---|
Intervention(s) to be implemented | TeLCIP | TMI, MeMo and TRIAGE | TelCIP and MeMo | Teach-back method and comprehensible prescription labels |
Project Leader(s) | Outpatient pharmacist | Community pharmacist | A Community Pharmacist and a policy adviser | A (non-practicing) pharmacist and a community pharmacist |
Involved healthcare providers | Outpatient pharmacy, 14 community pharmacies and linked GPs | Three community pharmacies and linked GPs | Five community pharmacies and linked GPs, a hospital and a home care organization | Two community pharmacies and their affiliated GPs |
Patient population | Cardiovascular disease patients at first dispensing of medication | All chronic disease patients using the repeat dispensing service | Cardiovascular disease patients | All patients at first dispensing of medication, of which two third have low health literacy |
Period | December 2020 up until December 2022 | December 2020 up until December 2022 | December 2020 up until December 2022 | December 2020 up until July 2022 |